Invesco S&P Midcap 400 Pure Growth ETF (RFG)
| Assets | $308.68M |
| Expense Ratio | 0.35% |
| PE Ratio | 25.45 |
| Shares Out | 5.53M |
| Dividend (ttm) | $0.22 |
| Dividend Yield | 0.41% |
| Ex-Dividend Date | Dec 22, 2025 |
| Payout Frequency | Quarterly |
| Payout Ratio | 10.49% |
| Volume | 3,904 |
| Open | 55.62 |
| Previous Close | 55.82 |
| Day's Range | 53.79 - 55.62 |
| 52-Week Low | 37.89 |
| 52-Week High | 59.05 |
| Beta | 1.14 |
| Holdings | 96 |
| Inception Date | Mar 1, 2006 |
About RFG
Fund Home PageThe Invesco S&P Midcap 400 Pure Growth ETF (RFG) is an exchange-traded fund that is based on the S&P Mid Cap 400 Pure Growth index. The fund tracks a factor-weighted index of the S&P 400 companies exhibiting the strongest growth factors. RFG was launched on Mar 1, 2006 and is issued by Invesco.
Top 10 Holdings
20.28% of assets| Name | Symbol | Weight |
|---|---|---|
| Valaris Limited | VAL | 2.35% |
| TechnipFMC plc | FTI | 2.31% |
| Woodward, Inc. | WWD | 2.15% |
| Five Below, Inc. | FIVE | 2.03% |
| MasTec, Inc. | MTZ | 1.96% |
| Arrowhead Pharmaceuticals, Inc. | ARWR | 1.94% |
| Sterling Infrastructure, Inc. | STRL | 1.92% |
| Lumentum Holdings Inc. | LITE | 1.90% |
| Carpenter Technology Corporation | CRS | 1.88% |
| Halozyme Therapeutics, Inc. | HALO | 1.83% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | $0.02869 | Dec 26, 2025 |
| Sep 22, 2025 | $0.04076 | Sep 26, 2025 |
| Jun 23, 2025 | $0.12042 | Jun 27, 2025 |
| Mar 24, 2025 | $0.03309 | Mar 28, 2025 |
| Dec 23, 2024 | $0.02827 | Dec 27, 2024 |
| Sep 23, 2024 | $0.03531 | Sep 27, 2024 |
Performance
RFG had a total return of 20.24% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.18%.
News
RFG: A Pure Play On Mid-Cap Growth
Invesco S&P MidCap 400® Pure Growth ETF is a fund focusing on mid-cap growth stocks, offering exposure to a selection of US midcap equity stocks with growth characteristics. The RFG fund tracks the S&...
RFG: Investors Should Consider Disadvantages Carefully
RFG deploys a pure-growth strategy in the mid-cap universe only to end up being overweight in large caps. That is certainly not a fundamental, intolerable flaw, yet this is nonetheless a facet SMID in...
Reasons For Midstream Investors To Be Calm Amid Today's Stock Market Storm
Oil and gas midstream stocks are not E&Ps, though they're trading as if they were. Oil macro conditions will remain positive for midstream above $70 per barrel.
An Interesting Opportunity Is Brewing With Mid-Cap ETFs
Among the many asset classes that performed well in the first quarter were mid-cap stocks. In the first three months of the year, the S&P MidCap 400 Index returned 14.8 percent, beating the S&P 500 by...